BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,995	5,186	7,023	1,139	2,455	8,716
Market Cap Growth	15.28%	-26.16%	516.57%	-53.61%	-71.83%	101.23%
Enterprise Value	10,242	6,661	8,229	2,271	3,264	8,544
Last Close Price	47.27	27.44	40.37	7.62	16.68	71.11
PS Ratio	70.09	23.37	754.92	14.67	35.22	1056.59
PB Ratio	-	-3.56	-5.23	-0.91	-2.84	80.79
P/TBV Ratio	-	-	-	-	-	150.52
EV/Sales Ratio	80.38	30.02	884.51	29.25	46.81	1035.70
Debt / Equity Ratio	-1.13	-1.19	-1.30	-1.38	-1.99	4.60
Asset Turnover	0.15	0.30	0.02	0.10	0.08	0.01
Quick Ratio	4.31	4.44	3.04	4.03	6.34	6.35
Current Ratio	4.57	4.67	3.32	4.52	6.58	6.72
Return on Equity (ROE)	-	-	-	-	-	-173.15%
Return on Assets (ROA)	-48.27%	-47.83%	-64.08%	-35.80%	-41.75%	-44.42%
Return on Capital (ROIC)	-91.66%	-104.60%	-85.54%	-43.72%	-48.94%	-50.63%
Earnings Yield	-7.48%	-10.33%	-9.16%	-42.24%	-22.91%	-5.15%
FCF Yield	-5.61%	-10.06%	-7.53%	-37.25%	-20.82%	-4.67%
Buyback Yield / Dilution	-11.59%	-14.30%	-10.39%	-2.16%	-22.34%	-12.27%

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q